AnyGen Co., Ltd. The company develops bio-new drugs and essential materials, especially new drug candidates based on physiologically active peptides, biologically functional materials, and chemical nano materials. We also develop raw materials for drugs and the mass production of peptides. Especially, we have been successful on the mass production of peptides for pre-clinical trials and cosmetics in 2006 and recorded a high growth rate in the international business including a contract with the a big Pharmaceutical Company in Japan. We are going to build a cGMP facility and a mass production system based on high quality and advanced techniques in near future that allow us to lead the market of raw materials for drugs. Our mission is to develop the core technologies through active networkings with national and international research groups to bring lead products toward commercialization, while at the same time achieving and sustaining stable cash position through licensing-in/licensing-out We are committed to achieving and sustaining growth well into the future by developing novel drugs having high marketing potentials based on stable cash-flow in the manufacturing raw materials for drugs.